Scientifically unsupported therapies in the treatment of young children with autism spectrum disorders

Pediatric Annals

Volumn 36, Issue 8, 2007, Pages 497-505

  Schechtman, Merryl A ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAMOTIDINE; IMMUNOGLOBULIN G; MEASLES MUMPS RUBELLA VACCINE; MERCURY; THIOMERSAL; VANCOMYCIN;

AUTISM; CANDIDA ALBICANS; CLINICAL TRIAL; COMMUNICATION SKILL; DEVELOPMENTAL DISORDER; DIARRHEA; DIETARY INTAKE; EVIDENCE BASED MEDICINE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERBARIC OXYGEN; IMMUNE RESPONSE; IMMUNE SYSTEM; MASSAGE; MUSIC THERAPY; REVIEW; SCIENTIFIC LITERATURE; SOCIAL INTERACTION; VITAMIN SUPPLEMENTATION;

EID: 34648833202     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20070801-12     Document Type: Review

References (47)

1. Fombonne E, Simmons H, Ford T, Meltzer H, Goodman R. Prevalence of pervasive developmental disorders in the British nationwide survey of child mental health. J Am Acad Child Adolesc Psychiatry. 2001;40(7):820-827.
2. McCann LJ, Newell SJ. Survey of paediatric complementary and alternative medicine use in children in health and chronic illness. Arch Dis Child. 2006;91(2):173-174.
3. Levy SE, Mandell Ds, Merhar S, et al. Use of complementary and alternative medicine among children recently diagnosed with autistic spectrum disorder. J Dev Behav Pediatrics. 2003;24:418-423.
4. Eisenberg DM. Advising patients who seek alternative medical therapies. Ann Intern Med. 1997;127(1):61-69.
5. Hanson E, Kalish LA, Bunce E, et al. Use of complementary and alternative medicine among children diagnosed with autism spectrum disorder. J Autism Dev Disord. 2007;37(4):628-636.
6. Harrington JW, Rosen L, Garnecho A, Patrick PA. Parental perceptions and use of complementary and alternative medicine practices for children with autistic spectrum disorders in private practice. J Dev Behav Pediatr. 2006;27(2 Suppl):S156-161.
7. Wong HH, Smith RG. Patterns of complementary and alternative therapy use in children diagnosed with autism spectrum disorders. J Autism Dev Disord. 2006;36(7):901-909.
8. Valicenti-McDermott M, McVicar K, Rapin I, Wershil BK, Cohen H, Shinnar S. Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J Dev Behav Pediatr. 2006; 27(2 Suppl):128-136.
9. Kuddo T, Nelson K. How common are gastrointestinal disorders in children with autism? Curr Opin Pediatr. 2003;15(3):339-343.
10. Goyal R, Hirano I. Mechanisms of disease: the enteric nervous system. N Engl J Med. 1996;334(17):1106-1115.
11. Erickson CA, Stigler Ka, Corkins MR, Posey DJ, Fitzgerald JF, McDougle CJ. Gastrointestinal factors in autistic disorder: a critical review. J Autism Dev Disord. 2005;35(6):713-727.
12. Feingold BF. The role of diet in behaviour. Ecol Dis. 1982:1(2-3):153-165.
13. Panskepp J. A neurochemical theory of autism. Trends in Neuroscience. 1979:2:174-177.
14. Reichelt K, Ekerm J, Scott H. Gluten, milk proteins and autism: dietary intervention effects on behavior and peptide secretion. J Appl Nutr. 1990;42:1-11.
15. Horvath K, Stefanatos G, Sokolski KN, Wachtel R, Nabors L, Tildon JT. Improved social and language skills after secretin administration in patients with autistic spectrum disorders. J Assoc Acad Minor Phys. 1998;9(1):9-15.
16. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia in nonspecific colitis and pervasive developmental disorder in children. Lancet. 1998;351(9103):637-641.
17. Warren RP, Margaretten NC, Pace NC, Foster A. Immune abnormalities in patients with autism. J Autism Dev Disord. 1986:16(2):189-197.
18. Singh VK, Warren RP, Odell JD, Warren WL, Cole P. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav Immunol. 1993;7(1):97-103.
19. Croen LA, Grether JK, Yoshida CK, Odouli R, Van de Water J. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorder: a case-control study. Arch Pediatr Adolesc Med. 2005; 159(2):451-457.
20. Konstantareas MM, Homatidis S. Brief report: ear infections in autistic and normal children. J Autism Dev Disord. 1987;17(4):585-594.
21. Valicenti-McDermott, McVicar K, Cohen H, et al. Gastrointestinal problems and family history of autoimmune diseases are more common in children with autistic spectrum disorders with language regression than those without regression. Poster presentation at the 2006 Pediatric Academic Society annual meeting. San Francisco,CA. April 29,2006. Abstract # 752977.
22. Levy SE, Hyman SL. Novel treatments for autistic spectrum disorder. Ment Retard Dev Disabil Res Rev 2005;11(2):131-142.
23. Murch SH, Anthony A, Casson DH, et al. Reaction of an interpretation. Lancet. 2004;363(9411):750.
24. Madsen KM, Lauritsen MB, Pedersen CB, et al. Thimerosal and the occurrence of autism: negative ecological evidence form Danish population-based data. Pediatrics. 2003;112(3 Pt 1):604-606.
25. Stratton K, Gable G, McCormick M, eds. Immunization Safety Reviews: Thimerosal containing vaccines and neurodevelopmental disorder. Washington, DC: National Academy Press; 2001.
26. Sandler RH, Finegold SM, Bolte ER, et al. Short term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol. 2000;15(7):429-435.
27. Crook WG. Nutrition, food allergies, and environmental toxins. J Learn Disabil. 1987;20(5):260-261.
28. Bernard S, Enayati A, Binstock T, et al. Autism: a unique type of mercury poisoning. Retrieved November 2006 from: http://www.cureautismnow.org/sciwatch/ invest.cfm. Accessed July 16, 2007.
29. Dietrich KN, Ware JJ, Salganik M, et al, and the Treatment of Lead Exposed Children Clinical Trial Group. Effect of chelation therapy on the neuropsychological and behavioral development of lead exposed children after school entry. Pediatrics. 2004;114(1):19-26.
30. Brown MJ, Willis T, Omalu B, Leiker R. Deaths resulting from hypocalcemia after administration of edetate disodium. Pediatrics. 2006;118(27):e534-536.
31. Thimerosal in vaccines: A joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR Wkly Rep. 1999;48(26):563-565.
32. Pauling L. Orthomolecular psychiatry. Science. 1968;160(825):265-271.
33. Rimland B, Calloway E, Dreyfus P. The effect of high doses of Vitamin B6 on autistic children: a double blind crossover study. Am J Psychiatry. 1978;135(4):472-475.
34. Nye C, Brice A. Combined vitamin B6-magnesium treatment in autism spectrum disorder. Cochrane Review 2002. In: The Cochrane Library, Issue 2: Oxford, UK; 2002.
35. Dolske MC, Spollen J, McKay S, Lancashire E, Tolbert L. A preliminary study of ascorbic acid as supplemental therapy for autism. Prog Neuropsychopharmacol Biol Psychiatry. 1993;17(5):765-774.
36. James SJ, Cutler P, Melnyk S, et al. Metabolic biomarkers of increased oxidative stress and methylation capacity in children with autism. Am J Clin Nutr. 2004;80(6):1611-1617.
37. Rimland B. Dimethyglycine (DMG) a non-toxic metabolite and autism. Autism Research Review, Intl. 1990;4(2):3.
38. Bolman W, Richmond J. A double blind, placebo-controlled crossover pilot trial of low dose dimethylglycine in patients with autistic disorder. J Autism Dev Disord. 1999;29(3):191-194.
39. Richardson AJ. Omega-3 fatty acids in ADHD and neurodevelopmental disorders. Int Rev Psychiatry. 2006;18(2):155-172.
40. Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR, Mosovich S. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Aspergers disorders. Neuropsychopharmacology. 2003;28(1):193-198.
41. Ayres AJ. Sensory Integration and Learning Disorders. Los Angeles, CA: Western Psychological Services; 1972.
42. Biklen D, Morton M, Gold D, et al. Implications for individuals with autism. Topics in Language Disorders. 1992;12(4):1-28.
43. American Academy of Pediatrics Committee on Children with Disabilities. Auditory Integration Training and Facilitated Communication for Autism. Pediatrics. 1998;102(2 Pt 1)431-433.
44. Stehli A. The Sound of a Miracle: A Child's Triumph Over Autism. New York, NY: Doubleday; 1991.
45. Gravel J. Auditory integration training: placing the burden of proof. American Journal of Speech-Language Pathology. 1994;3(2):25-29.
46. Tibbies P, Edelsberg J. Hyperbaric oxygen therapy. N Engl J Med. 1996(20);334(25):1642-1648.
47. Rossignol DA, Rossignol LW. Hyperbaric oxygen therapy may improve symptoms in autistic children. Med Hypotheses. 2006;67(2):216-228.